Page 1 of 1

2021-Beyrend et al-preprint

PostPosted: Mon Jan 03, 2022 6:14 pm
by mleipold
"OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum"
Guillaume Beyrend, Tetje C. van der Sluis, Esmé T.I. van der Gracht, Tamim Abdelaal, Simon P. Jochems, Robert A. Belderbos, Thomas H. Wesselink, Suzanne van Duikeren, Floortje J. van Haften, Anke Redeker, Elham Beyranvand Nejad, Marcel Camps, Kees LMC Franken, Margot M. Linssen, Peter Hohenstein, Noel F.C.C. de Miranda, Hailiang Mei, Adriaan D. Bins, John B.A.G. Haanen, Joachim G. Aerts, Ferry Ossendorp, Ramon Arens
bioRxiv, posted December 25, 2021
https://doi.org/10.1101/2021.12.24.474145

- will update when/if this is peer-reviewed and published

- no dataset accession given

Re: 2021-Beyrend et al-preprint

PostPosted: Fri Feb 17, 2023 5:26 pm
by mleipold
Now published:

Cell Rep Med. 2023
https://doi.org/10.1016/j.xcrm.2023.100939

- no CyTOF dataset accession given